[go: up one dir, main page]

AU2002214505A1 - New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives - Google Patents

New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives

Info

Publication number
AU2002214505A1
AU2002214505A1 AU2002214505A AU1450502A AU2002214505A1 AU 2002214505 A1 AU2002214505 A1 AU 2002214505A1 AU 2002214505 A AU2002214505 A AU 2002214505A AU 1450502 A AU1450502 A AU 1450502A AU 2002214505 A1 AU2002214505 A1 AU 2002214505A1
Authority
AU
Australia
Prior art keywords
tetrahydroimidazo
pyridine derivatives
new use
new
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214505A
Inventor
Olivier Besencon
Patrizia Caldirola
Johan Ohman
Rolf Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004101A external-priority patent/SE0004101D0/en
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of AU2002214505A1 publication Critical patent/AU2002214505A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002214505A 2000-11-09 2001-11-09 New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives Abandoned AU2002214505A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0004101A SE0004101D0 (en) 2000-11-09 2000-11-09 New use
SE0004101 2000-11-09
US25215600P 2000-11-20 2000-11-20
US60252156 2000-11-20
PCT/SE2001/002523 WO2002038153A1 (en) 2000-11-09 2001-11-09 New use of 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine derivatives

Publications (1)

Publication Number Publication Date
AU2002214505A1 true AU2002214505A1 (en) 2002-05-21

Family

ID=26655299

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214505A Abandoned AU2002214505A1 (en) 2000-11-09 2001-11-09 New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives

Country Status (2)

Country Link
AU (1) AU2002214505A1 (en)
WO (1) WO2002038153A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326519C (en) 2001-12-14 2007-07-18 诺沃挪第克公司 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7071355B2 (en) 2002-12-23 2006-07-04 4 Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7247736B2 (en) 2002-12-23 2007-07-24 4Sc Ag Method of identifying inhibitors of DHODH
AR042941A1 (en) 2003-01-27 2005-07-06 Fujisawa Pharmaceutical Co DERIVATIVES OF TIAZOL, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF INHIBITING MEDICINES OF VASCULAR ADHESION PROTEIN-1 (VAP-1)
FI20031927A0 (en) * 2003-12-31 2003-12-31 Faron Pharmaceuticals Oy Therapeutically active substances and their use
US8119651B2 (en) 2004-01-30 2012-02-21 Biotie Therapies Corp. Compositions useful especially for treatment or prevention of metabolic syndrome
JP2007519688A (en) * 2004-01-30 2007-07-19 ファロン ファーマシューティカルズ オサケ ユキチュア Composition particularly effective for the treatment or prevention of metabolic syndrome
EP2283833A3 (en) 2004-02-25 2013-07-10 La Jolla Pharmaceutical Co. Amines and amides for the treatment of diseases
JP4978464B2 (en) * 2004-07-27 2012-07-18 アステラス製薬株式会社 Thiazole derivatives having VAP-1 inhibitor activity
TWI437986B (en) 2008-01-31 2014-05-21 R Tech Ueno Ltd Thiazole derivative and use thereof as vap-1 inhibitor
TWI490214B (en) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
EP2328895B1 (en) * 2008-09-16 2013-03-27 Proximagen Limited Pyrazolo[4,3-c]pyridine compounds and their use as inhibitors of SSAO
EA019167B1 (en) * 2008-09-16 2014-01-30 Проксимаген Лимитед Compounds inhibiting ssao activity
US20120010188A1 (en) 2008-12-04 2012-01-12 Promimagen Ltd. Imidazopyridine Compounds
UA112154C2 (en) 2009-09-08 2016-08-10 Біоті Терапіс Корп. APPLICATION OF FULLY HUMAN ANTI-VAP-1-ANTIBODY FOR TREATMENT OF FIBROUS CONDITIONS
TW201116276A (en) 2009-09-16 2011-05-16 Astellas Pharma Inc Glycine compounds
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
FI20115234A0 (en) 2011-03-08 2011-03-08 Biotie Therapies Corp New pyridazinone and pyridone compounds
RS54965B1 (en) 2011-03-15 2016-11-30 Astellas Pharma Inc Guanidine compound
GB201115853D0 (en) 2011-09-14 2011-10-26 Proximagen Ltd New enzyme inhibitor compounds
CA2847193A1 (en) * 2011-09-14 2013-03-21 Proximagen Limited New enzyme inhibitor compounds
GB201304526D0 (en) 2013-03-13 2013-04-24 Proximagen Ltd New compounds
GB201304527D0 (en) 2013-03-13 2013-04-24 Proximagen Ltd New compounds
US9186361B2 (en) 2013-03-15 2015-11-17 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US9296754B2 (en) 2013-03-15 2016-03-29 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US9233961B2 (en) * 2013-03-15 2016-01-12 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
AU2014279863A1 (en) 2013-06-12 2016-01-28 Proximagen Limited New therapeutic uses of enzyme inhibitors
AR098436A1 (en) 2013-11-19 2016-05-26 Actelion Pharmaceuticals Ltd TRIPYCLIC COMPOUNDS OF PIPERIDINE
TW201609721A (en) 2013-11-19 2016-03-16 艾克泰聯製藥有限公司 Tricyclic imidazole compounds
AU2014364565B2 (en) 2013-12-19 2017-06-15 Novartis Ag [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis
EP3131539B1 (en) 2014-04-15 2018-12-05 Pécsi Tudományegyetem Semicarbazide-sensitive amine oxidase inhibitors for use as analgesics in traumatic neuropathy and neurogenic inflammation
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
GB201416446D0 (en) * 2014-09-17 2014-10-29 Proximagen Ltd New enzyme inhibitor compounds
GB201416444D0 (en) * 2014-09-17 2014-10-29 Proximagen Ltd New compounds
GB201507031D0 (en) 2015-04-24 2015-06-10 Proximagen Ltd New pharmaceutical salt forms
GB201507036D0 (en) 2015-04-24 2015-06-10 Proximagen Ltd Crystalline enzyme inhibitor compound
MA42034A (en) * 2015-05-04 2018-03-14 Actelion Pharmaceuticals Ltd TRICYCLIC PIPERIDINIC COMPOUNDS
JP2018076236A (en) 2015-06-05 2018-05-17 株式会社アールテック・ウエノ Pharmaceutical composition for treating cancer
GB201513115D0 (en) * 2015-07-24 2015-09-09 Proximagen Ltd New therapeutic compound and use in therapy
AU2016366635A1 (en) 2015-12-07 2018-06-21 Benevolentai Cambridge Limited VAP-1 inhibitors for treating pain
CN108033945A (en) * 2017-12-29 2018-05-15 佛山汉方中医医院有限公司 A kind of adamantane and nitropyridine structural compounds and purposes
CN107935992A (en) * 2017-12-29 2018-04-20 佛山汉方中医医院有限公司 One kind contains adamantane and haloperidid structural compounds and purposes
CN108129458A (en) * 2017-12-29 2018-06-08 佛山汉方中医医院有限公司 A kind of adamantane and dimethylaminopyridine structural derivative, preparation method and the usage
CN108033946A (en) * 2017-12-29 2018-05-15 佛山汉方中医医院有限公司 A kind of SSAO inhibitor, preparation method and its usage containing adamantane structure
CN108084154A (en) * 2017-12-29 2018-05-29 佛山汉方中医医院有限公司 A kind of adamantane and amido pyridine structure derivative, preparation method and the usage
CN108191825A (en) * 2017-12-29 2018-06-22 佛山汉方中医医院有限公司 A kind of methyl adamantane and nitropyridine structural derivative and application thereof
CN107935989A (en) * 2017-12-29 2018-04-20 佛山汉方中医医院有限公司 Adamantane and itrile group pyridine structure compound, preparation method and the usage
CN107935990A (en) * 2017-12-29 2018-04-20 佛山汉方中医医院有限公司 Containing adamantane and alcoxyl pyridine structure compound, preparation method and the usage
CN107935993A (en) * 2017-12-29 2018-04-20 佛山汉方中医医院有限公司 Methyl adamantane and nitropyridine structural derivative, Its Preparation Method And Use
CN108084155A (en) * 2017-12-29 2018-05-29 佛山汉方中医医院有限公司 SSAO inhibitor of methyl adamantane and alcoxyl pyridine structure and application thereof
CN109988147A (en) * 2017-12-29 2019-07-09 佛山汉方中医医院有限公司 SSAO inhibitor, preparation method and its usage containing adamantane structure
CN108191823A (en) * 2017-12-29 2018-06-22 佛山汉方中医医院有限公司 A kind of alkyl substitution adamantane SSAO inhibitor, preparation method and its usage
CN107915719A (en) * 2017-12-29 2018-04-17 佛山汉方中医医院有限公司 SSAO inhibitor of a kind of methyl adamantane and pyridine structure and application thereof
CN108191824A (en) * 2017-12-29 2018-06-22 佛山汉方中医医院有限公司 A kind of methyl adamantane and dimethylaminopyridine structural derivative, Its Preparation Method And Use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141899A (en) * 1976-01-07 1979-02-27 Societa' Farmaceutici Italia S.P.A. 4,5,6,7-Tetrahydroimidazo-[4,5-c]-pyridine derivatives
GB8501542D0 (en) * 1985-01-22 1985-02-20 Erba Farmitalia 4 5 6 7-tetrahydro-imidazo(4 5-clpyridine derivatives
EP0639972A1 (en) * 1992-05-15 1995-03-01 University Of Saskatchewan Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis
JP2002542245A (en) * 1999-04-16 2002-12-10 ノボ ノルディスク アクティーゼルスカブ Substituted imidazoles, their manufacture and use

Also Published As

Publication number Publication date
WO2002038153A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002214505A1 (en) New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives
AU2002216028A1 (en) Novel carbamate-substituted pyrazolopyridine derivatives
AU2002221827A1 (en) Novel lactame-substituted pyrazolopyridine derivatives
AU2002220692A1 (en) Novel pyridine-substituted pyrazolopyridine derivatives
AU2001295992A1 (en) Imidazopyridine derivatives
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2002231628A1 (en) 4-6-diphenyl pyridine derivatives as antiinflammatory agents
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2002352142A1 (en) Pyrazolopyridine derivatives
AU2002224038A1 (en) Benzimidazole derivatives
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2002356533A1 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
AU2001278694A1 (en) Avermectin derivatives
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2001242523A1 (en) Aminophenyl pyrimidone derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives